moderna emergency use authorization

News

COVID-19, Moderna and Spikevax vaccine

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

Medical Dialogues · 2h

Moderna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID risk

Just The News · 2d

In era of skepticism, FDA clears Moderna COVID vaccination for some kids up to 11 years old

ABC7 San Francisco1d

Moderna seeks emergency use authorization for Covid-19 vaccine for ...

NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said ...

StockStory.org on MSN2d

Why Moderna (MRNA) Stock Is Up Today

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

COVID-19, Moderna and Spikevax vaccine

Trending now